Citation: Jinna Yang, Changbai Huang, Yao Feng, Junfang He, Yang Liu, Ping Zhang, Chao Liu. Adaptor protein complex 1 gamma 1 subunit is an important host factor involved in both Zika virus and dengue virus infections .VIROLOGICA SINICA, 2025, 40(6) : 874-883.  http://dx.doi.org/10.1016/j.virs.2025.07.012

Adaptor protein complex 1 gamma 1 subunit is an important host factor involved in both Zika virus and dengue virus infections

  • Mosquito-borne flaviviruses, such as Zika virus (ZIKV) and dengue virus (DENV), cause diverse severe clinical manifestations including fever, rash, hepatitis, arthralgia, and congenital anomalies. Here, we identified a host factor, the adaptor protein complex 1 gamma 1 subunit (AP1G1), which plays an important role in both ZIKV and dengue virus 2 (DENV2) infections. We explored the role of AP1G1 in ZIKV and DENV2 infections using CRISPR/Cas9 gene editing technology and RNA interference (RNAi) techniques. Knockout or silencing of AP1G1 decreases the replication of ZIKV and DENV2 in multiple human cell lines. Intriguingly, depletion of AP1G1 results in a significant reduction in ZIKV at an early stage, but decreases DENV2 replication levels during the late stage, suggesting that AP1G1 plays distinct roles in the infection by ZIKV and DENV2. Furthermore, we determined that AP1G1 mediates ZIKV-endosomal membrane fusion through inhibitor experiments and fluorescence labeling assays. Mechanistically, we found that AP1G1 exerts its pro-viral effect through binding to the ZIKV envelope glycoprotein (E protein). This interaction promotes the fusion of viral and endosomal membranes, during which the ZIKV genomic RNAs are released from the endosome into the cytoplasm, a process that facilitates viral replication. However, for DENV2 infection, AP1G1 primarily affects its viral RNA replication stage, rather than the fusion of virus-endosomal membrane. Taken together, our work demonstrates that AP1G1 plays a pro-viral role in both ZIKV and DENV2 infections via distinct mechanisms, highlighting its potential as a therapeutic target for antiviral strategies.

  • 加载中
  • 10.1016j.virs.2025.07.012.docx
    1. Agrawal, T., Schu, P.,Medigeshi, G.R., 2013. Adaptor protein complexes-1 and 3 are involved at distinct stages of flavivirus life-cycle. Sci Rep, 3, 1813.

    2. Allison, S.L., Schalich, J., Stiasny, K., Mandl, C.W., Kunz, C.,Heinz, F.X., 1995. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol, 69, 695-700.

    3. Anitei, M., Stange, C., Parshina, I., Baust, T., Schenck, A., Raposo, G., Kirchhausen, T.,Hoflack, B., 2010. Protein complexes containing CYFIP/Sra/PIR121 coordinate Arf1 and Rac1 signalling during clathrin-AP-1-coated carrier biogenesis at the TGN. Nat Cell Biol, 12, 330-340.

    4. Ashfaq, U.A., Javed, T., Rehman, S., Nawaz, Z.,Riazuddin, S., 2011. Lysosomotropic agents as HCV entry inhibitors. Virol J, 8, 163.

    5. Bonifacino, J.S., 2014. Adaptor proteins involved in polarized sorting. J Cell Biol, 204, 7-17.

    6. Bonifacino, J.S.,Traub, L.M., 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem, 72, 395-447.

    7. Collins, D.R.,Collins, K.L., 2014. HIV-1 accessory proteins adapt cellular adaptors to facilitate immune evasion. PLoS Pathog, 10, e1003851.

    8. Cruz-Oliveira, C., Freire, J.M., Conceicao, T.M., Higa, L.M., Castanho, M.A.,Da Poian, A.T., 2015. Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol Rev, 39, 155-170.

    9. Delevoye, C., Hurbain, I., Tenza, D., Sibarita, J.B., Uzan-Gafsou, S., Ohno, H., Geerts, W.J., Verkleij, A.J., Salamero, J., Marks, M.S.,Raposo, G., 2009. AP-1 and KIF13A coordinate endosomal sorting and positioning during melanosome biogenesis. J Cell Biol, 187, 247-264.

    10. Doyle, C.A., Busey, G.W., Iobst, W.H., Kiessling, V., Renken, C., Doppalapudi, H., Stremska, M.E., Manjegowda, M.C., Arish, M., Wang, W., et al., 2024. Endosomal fusion of pH-dependent enveloped viruses requires ion channel TRPM7. Nat Commun, 15, 8479.

    11. Ferrie, M., Alexandre, V., Montpellier, C., Bouquet, P., Tubiana, T., Meziere, L., Ankavay, M., Bentaleb, C., Dubuisson, J., Bressanelli, S., Aliouat-Denis, C.M., Rouille, Y.,Cocquerel, L., 2024. The AP-1 adaptor complex is essential for intracellular trafficking of the ORF2 capsid protein and assembly of Hepatitis E virus. Cell Mol Life Sci, 81, 335.

    12. Gould, E.A.,Solomon, T., 2008. Pathogenic flaviviruses. Lancet, 371, 500-509.

    13. Guzman, M.G.,Harris, E., 2015. Dengue. Lancet, 385, 453-465.

    14. Kleinfelter, L.M., Jangra, R.K., Jae, L.T., Herbert, A.S., Mittler, E., Stiles, K.M., Wirchnianski, A.S., Kielian, M., Brummelkamp, T.R., Dye, J.M.,Chandran, K., 2015. Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion. mBio, 6, e00801.

    15. Liu, Y., Xu, P., Rivara, S., Liu, C., Ricci, J., Ren, X., Hurley, J.H.,Ablasser, A., 2022. Clathrin-associated AP-1 controls termination of STING signalling. Nature, 610, 761-767.

    16. Martina, B.E., Koraka, P.,Osterhaus, A.D., 2009. Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev, 22, 564-581.

    17. Mukhopadhyay, S., Kuhn, R.J.,Rossmann, M.G., 2005. A structural perspective of the flavivirus life cycle. Nat Rev Microbiol, 3, 13-22.

    18. Musso, D., Bossin, H., Mallet, H.P., Besnard, M., Broult, J., Baudouin, L., Levi, J.E., Sabino, E.C., Ghawche, F., Lanteri, M.C.,Baud, D., 2018. Zika virus in French Polynesia 2013-14: anatomy of a completed outbreak. Lancet Infect Dis, 18, e172-e182.

    19. Ochiai, H., Sakai, S., Hirabayashi, T., Shimizu, Y.,Terasawa, K., 1995. Inhibitory effect of bafilomycin A1, a specific inhibitor of vacuolar-type proton pump, on the growth of influenza A and B viruses in MDCK cells. Antiviral Res, 27, 425-430.

    20. Ohno, H., Aguilar, R.C., Yeh, D., Taura, D., Saito, T.,Bonifacino, J.S., 1998. The medium subunits of adaptor complexes recognize distinct but overlapping sets of tyrosine-based sorting signals. J Biol Chem, 273, 25915-25921.

    21. Pierson, T.C.,Diamond, M.S., 2020. The continued threat of emerging flaviviruses. Nat Microbiol, 5, 796-812.

    22. Rebendenne, A., Roy, P., Bonaventure, B., Chaves Valadao, A.L., Desmarets, L., Arnaud-Arnould, M., Rouille, Y., Tauziet, M., Giovannini, D., Touhami, J., et al., 2022. Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal HCoVs. Nat Genet, 54, 1090-1102.

    23. Robinson, M.S., 2004. Adaptable adaptors for coated vesicles. Trends Cell Biol, 14, 167-174.

    24. Shen, Q.T., Ren, X., Zhang, R., Lee, I.H.,Hurley, J.H., 2015. HIV-1 Nef hijacks clathrin coats by stabilizing AP-1:Arf1 polygons. Science, 350, aac5137.

    25. Sirohi, D.,Kuhn, R.J., 2017. Zika Virus Structure, Maturation, and Receptors. J Infect Dis, 216, S935-s944.

    26. Slon Campos, J.L., Mongkolsapaya, J.,Screaton, G.R., 2018. The immune response against flaviviruses. Nat Immunol, 19, 1189-1198.

    27. Tao, X., Lu, Y., Qiu, S., Wang, Y., Qin, J.,Fan, Z., 2017. AP1G1 is involved in cetuximab-mediated downregulation of ASCT2-EGFR complex and sensitization of human head and neck squamous cell carcinoma cells to ROS-induced apoptosis. Cancer Lett, 408, 33-42.

    28. Tavares, L.A., Da Silva, E.M., Da Silva-Januario, M.E., Januario, Y.C., De Cavalho, J.V., Czernisz E, S., Mardones, G.A.,Dasilva, L.L., 2017. CD4 downregulation by the HIV-1 protein Nef reveals distinct roles for the γ1 and γ2 subunits of the AP-1 complex in protein trafficking. J Cell Sci, 130, 429-443.

    29. Villordo, S.M., Carballeda, J.M., Filomatori, C.V.,Gamarnik, A.V., 2016. RNA Structure Duplications and Flavivirus Host Adaptation. Trends Microbiol, 24, 270-283.

    30. Wang, X., Qian, C., Zhang, C., Hu, S., Asad, M., Yang, C., Liao, B., Guo, X., Zhang, C., Li, Q., Li, X., Huang, Q., Si, Y., Zhu, B., Cao, S.,Ye, J., 2025. Zika virus transmission in Aedes aegypti: A systematic study on the ability of mosquitoes to transmit the virus horizontally and vertically. Virol Sin, 40, 192-205.

    31. Yasamut, U., Tongmuang, N., Yenchitsomanus, P.T., Junking, M., Noisakran, S., Puttikhunt, C., Chu, J.J.,Limjindaporn, T., 2015. Adaptor Protein 1A Facilitates Dengue Virus Replication. PLoS One, 10, e0130065.

    32. Zaitseva, E., Yang, S.T., Melikov, K., Pourmal, S.,Chernomordik, L.V., 2010. Dengue virus ensures its fusion in late endosomes using compartment-specific lipids. PLoS Pathog, 6, e1001131.

    33. Zhao, F., Xu, Y., Lavillette, D., Zhong, J., Zou, G.,Long, G., 2018. Negligible contribution of M2634V substitution to ZIKV pathogenesis in AG6 mice revealed by a bacterial promoter activity reduced infectious clone. Sci Rep, 8, 10491.

  • 加载中

Figures(1)

Article Metrics

Article views(2054) PDF downloads(53) Cited by()

Related
Proportional views

    Adaptor protein complex 1 gamma 1 subunit is an important host factor involved in both Zika virus and dengue virus infections

      Corresponding author: Ping Zhang, zhangp36@mail.sysu.edu.cn
      Corresponding author: Chao Liu, liuchao9@mail.sysu.edu.cn
    • a. Key Laboratory of Tropical Diseases Control, Sun Yat-sen University, Guangzhou, 510080, China;
    • b. Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, 510080, China;
    • c. School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, 999077, China

    Abstract: Mosquito-borne flaviviruses, such as Zika virus (ZIKV) and dengue virus (DENV), cause diverse severe clinical manifestations including fever, rash, hepatitis, arthralgia, and congenital anomalies. Here, we identified a host factor, the adaptor protein complex 1 gamma 1 subunit (AP1G1), which plays an important role in both ZIKV and dengue virus 2 (DENV2) infections. We explored the role of AP1G1 in ZIKV and DENV2 infections using CRISPR/Cas9 gene editing technology and RNA interference (RNAi) techniques. Knockout or silencing of AP1G1 decreases the replication of ZIKV and DENV2 in multiple human cell lines. Intriguingly, depletion of AP1G1 results in a significant reduction in ZIKV at an early stage, but decreases DENV2 replication levels during the late stage, suggesting that AP1G1 plays distinct roles in the infection by ZIKV and DENV2. Furthermore, we determined that AP1G1 mediates ZIKV-endosomal membrane fusion through inhibitor experiments and fluorescence labeling assays. Mechanistically, we found that AP1G1 exerts its pro-viral effect through binding to the ZIKV envelope glycoprotein (E protein). This interaction promotes the fusion of viral and endosomal membranes, during which the ZIKV genomic RNAs are released from the endosome into the cytoplasm, a process that facilitates viral replication. However, for DENV2 infection, AP1G1 primarily affects its viral RNA replication stage, rather than the fusion of virus-endosomal membrane. Taken together, our work demonstrates that AP1G1 plays a pro-viral role in both ZIKV and DENV2 infections via distinct mechanisms, highlighting its potential as a therapeutic target for antiviral strategies.

    Figure (1)  Reference (33) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return